Does Rallies show 13F holders for ELAN?

Yes. Rallies tracks hedge fund and 13F ownership data for ELAN, including fund names, share counts, latest tracked quarter, and position changes when available.

Is ELAN research on Rallies investment advice?

No. Rallies provides research, data, and educational context for ELAN. It does not provide personalized investment advice.

ELAN (Elanco Animal Health Incorporated Common Stock) Stock Analysis - Hedge Fund Holdings

Elanco Animal Health Incorporated Common Stock (ELAN) is a publicly traded Healthcare sector company. As of May 21, 2026, ELAN trades at $21.22 with a market cap of $9.95B and a P/E ratio of -41.81. ELAN moved +5.25% today. Year to date, ELAN is -9.54%; over the trailing twelve months it is +59.40%. Its 52-week range spans $8.02 to $27.72. Analyst consensus is strong buy with an average price target of $29.18. Rallies surfaces ELAN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns ELAN stock?

Hedge funds tracked by Rallies that own ELAN include Redmile Group, Panagora Asset, Eisler Capital, Maverick Capital, and Bridgewater Associates. The latest tracked quarter is Mar 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Elanco Animal Health Incorporated Common Stock.

ELAN Key Metrics

Key financial metrics for ELAN
Metric	Value
Price	$21.22
Market Cap	$9.95B
P/E Ratio	-41.81
EPS	$-0.50
Dividend Yield	0.00%
52-Week High	$27.72
52-Week Low	$8.02
Volume	201
Avg Volume	0
Revenue (TTM)	$4.89B
Net Income	$-242.00M
Gross Margin	55.06%

Top Hedge Funds Holding ELAN

Redmile Group holds 676.04K shares of ELAN, changed +0.00% as of Mar 31, 2024.
Panagora Asset holds 260.69K shares of ELAN, changed -0.71% as of Mar 31, 2026.
Eisler Capital holds 247.99K shares of ELAN, changed +0.00% as of Jun 30, 2024.
Maverick Capital holds 144.46K shares of ELAN, changed +35.52% as of Mar 31, 2026.
Bridgewater Associates holds 86.19K shares of ELAN, changed +288.98% as of Mar 31, 2026.

Latest ELAN News

Elanco jumps after Q1 beat and raised 2026 outlook on innovation momentum — May 6, 2026
Elanco jumps ahead of May 6 earnings, focus on guidance and innovation momentum — May 5, 2026
Elanco drops on FDA warning letter tied to Pradalex promotions ahead of Q1 report — Apr 27, 2026
Elanco slides 3% with no fresh headline as investors await Q1 earnings — Apr 23, 2026
Elanco slides 3% as traders de-risk ahead of Q1 report and key Befrena launch — Apr 21, 2026

Recent ELAN Insider Trades

Modi Rajeev A. bought 4.91K (~$99.94K) on May 15, 2026.
Simmons Jeffrey N bought 4.97K (~$99.84K) on May 15, 2026.

ELAN Analyst Consensus

12 analysts cover ELAN: 0 strong buy, 11 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $29.18.

Common questions about ELAN

Who owns ELAN stock?: Hedge funds tracked by Rallies that own ELAN include Redmile Group, Panagora Asset, Eisler Capital, Maverick Capital, and Bridgewater Associates. The latest tracked quarter is Mar 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Elanco Animal Health Incorporated Common Stock.
Does Rallies show 13F holders for ELAN?: Yes. Rallies tracks hedge fund and 13F ownership data for ELAN, including fund names, share counts, latest tracked quarter, and position changes when available.
Is ELAN research on Rallies investment advice?: No. Rallies provides research, data, and educational context for ELAN. It does not provide personalized investment advice.